🇺🇸 Fumarate, Tenofovir Disoproxil in United States

91 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Exposure During Pregnancy — 17 reports (18.68%)
  2. Aspartate Aminotransferase Increased — 12 reports (13.19%)
  3. Anaemia — 11 reports (12.09%)
  4. Alanine Aminotransferase Increased — 8 reports (8.79%)
  5. Nausea — 8 reports (8.79%)
  6. Vomiting — 8 reports (8.79%)
  7. Asthenia — 7 reports (7.69%)
  8. Diarrhoea — 7 reports (7.69%)
  9. Pyrexia — 7 reports (7.69%)
  10. Caesarean Section — 6 reports (6.59%)

Source database →

Fumarate, Tenofovir Disoproxil in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Fumarate, Tenofovir Disoproxil approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Fumarate, Tenofovir Disoproxil in United States?

ANRS, Emerging Infectious Diseases is the originator. The local marketing authorisation holder may differ — check the official source linked above.